Markets
NVAX Watch
Novavax
$6.09
$-0.185 -2.95%
1 Min 5 Min 15 Min Hourly Daily
Assets Gross Profit Revenue Earnings
Chart Sentiment News Fundamentals About
Jake__Wujastyk
@jake__wu...
49.1% Winrate 2.5% Avg Gain 43.9% S&P Beat
Bought NVAX Shares
156d agoSwungBullish
down -4.84% At 8.27, Exited 7.87
This is the BS media shit thats probably going to move this and other names like $MRNA $PFE etc.
Exited 149d ago
0 0
Stonks
@stocks
48.7% Winrate 25.2% Avg Gain 15.8% S&P Beat
Bought NVAX Shares
180d agoSwungBullish
down -10.36% At 9.07, Exited 8.13
I believe Novavax is currently undervalued at around $9 and has strong potential to double or even triple its stock price this year. The recent buyout... Read More
Exited 173d ago
0 0
MoonTrades7
@moontrad...
13.2% Winrate -14.3% Avg Gain -1896.5% S&P Beat
Bought NVAX Calls
183d agoDaytradedBullish
down -11.59% At 0.28, Exited 0.24
Contract: 10 Strike Call for Jan 31
THIS CAN GO 1,000%
Exited 182d ago
0 0
Scalp
@scalpgan...
45.7% Winrate 99.7% Avg Gain 4606.9% S&P Beat
Bought NVAX Shares
228d agoSwungBullish
down -3.76% At 9.04, Exited 8.7
I've got a strong position in NVAX right now because of three major catalysts that the market hasn't fully absorbed yet. With recent milestones reache... Read More
Exited 221d ago
0 0
Long
@long_gam...
45.9% Winrate 15.1% Avg Gain 135.0% S&P Beat
Shorted NVAX Shares
257d agoSwungBearish
down -19.13% At 7.11, Exited 8.47
Given the disconnect between the positive developments in the malaria vaccine and NVAX's poor stock performance, I believe it’s wise to short NVAX. Th... Read More
Exited 250d ago
0 0
Degenerate
@wsb
43.7% Winrate 14.3% Avg Gain 453.1% S&P Beat
Bought NVAX Shares
297d agoSwungBullish
down -7.27% At 13.61, Exited 12.62
I'm really optimistic about NVAX, especially after their deal with Sanofi which should drive revenue and growth. With a 30% short interest, I'm antici... Read More
Exited 289d ago
0 0
Biostonks69
@9n6g89hh...
50.0% Winrate -2.9% Avg Gain 2.8% S&P Beat
Bought NVAX Shares
347d agoInvestedBullish
down -52.95% At 12.98, Now 6.11
Riding the wave of the smallpox fear. Company has good financials with $1B cash on hand and in a good position to receive government funding, grants, ... Read More
Degenerate
@wsb
43.7% Winrate 14.3% Avg Gain 453.1% S&P Beat
Bought NVAX Shares
347d agoInvestedBullish
down -44.12% At 12.92, Exited 7.22
Novavax is well-positioned to capitalize on the monkeypox outbreak with its proven vaccine platform, strong financial position, and potential for gove... Read More
Exited 257d ago
1 1
Two
@two-sigm...
58.6% Winrate 12.2% Avg Gain -21.0% S&P Beat
Bought NVAX Shares
1.1y agoInvestedBullish
down -51.88% At 12.73, Now 6.11
Trims & Adds [ ] Currently down $13.2M
[+] 303d ago
Added 656.9K shares @ 12.63
[+] 1.1y ago
Initial 1.3M shares @ 12.73
Renaissance
@renaissa...
56.9% Winrate 5.6% Avg Gain -11.6% S&P Beat
Bought NVAX Shares
1.1y agoInvestedBullish
down -51.83% At 12.73, Now 6.11
Trims & Adds [ ] Currently down $13.6M
[+] 303d ago
Added 954.6K shares @ 12.63
[+] 1.1y ago
Initial 1.1M shares @ 12.73
Point72
@point72-...
51.8% Winrate 5.6% Avg Gain -17.7% S&P Beat
Bought NVAX Shares
2.3y agoInvestedBullish
up 38.62% At 6.93, Now 6.11
Trims & Adds [ ] Currently up $1.4M
[-] 303d ago
Trimmed 34.8K shares @ 12.63
[-] 1.1y ago
Trimmed 151.5K shares @ 12.73
[+] 1.3y ago
Added 100.0K shares @ 4.65
[+] 1.6y ago
Added 79.8K shares @ 5.03
[-] 1.8y ago
Trimmed 255.0K shares @ 7.09
[+] 2.1y ago
Added 70.0K shares @ 7.43
[+] 2.3y ago
Initial 310.0K shares @ 6.93
Two
@two-sigm...
58.6% Winrate 12.2% Avg Gain -21.0% S&P Beat
Bought NVAX Shares
2.6y agoInvestedBullish
down -37.59% At 9.79, Now 6.11
Sign in or create an account Get notifications, save trades, and more
google logo Continue with Google Continue with Email
By continuing, you agree to our Terms and Privacy Policy.